Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $261.07 +3.99%
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Piper Jaffray analyst Christopher Raymond lowered the price target on Abbvie (NYSE: ABBV) to $80.00 (from $90.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
- Netwealth Group Ltd. (NWL:AU) PT Lowered to AUD25.35 at Citi
- Pro Medicus Ltd. (PME:AU) (PMCUF) PT Lowered to AUD240 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
